Leader

Pulmonary preinvasive neoplasia

K M Kerr

Department of Pathology, Aberdeen Royal Infirmary and Aberdeen University Medical School, Foresterhill, Aberdeen AB25 2ZD, UK

Correspondence to:
Dr Kerr k.kerr{at}abdn.ac.uk

Advances in molecular biology have increased our knowledge of the biology of preneoplastic lesions in the human lung. The recently published WHO lung tumour classification defines three separate lesions that are regarded as preinvasive neoplasia. These are (1) squamous dysplasia and carcinoma in situ (SD/CIS), (2) atypical adenomatous hyperplasia (AAH), and (3) diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH). SD/CIS is graded in four stages (mild, moderate, severe, and CIS), based upon the distribution of atypical cells and mitotic figures. Most airways showing SD/CIS demonstrate a range of grades; many epithelia are hard to assess and the reproducibility of this complex system remains to be established. Detailed criteria are, however, welcome and provide an objective framework on which to compare various molecular changes. Alterations in gene expression and chromosome structure known to be associated with malignant transformation can be demonstrated in CIS, less so in dysplasias, but also in morphologically normal epithelium. The changes might be sequential, and their frequency and number increase with atypia. Less is known of the "risk of progression" of SD/CIS to invasive "central" bronchial carcinoma. It may take between one and 10 years for invasion to occur, yet the lesion(s) may be reversible if carcinogen exposure ceases.

AAH may be an important precursor lesion for peripheral "parenchymal" adenocarcinoma of the lung: the "adenoma" in an adenoma–carcinoma sequence. There is good morphological evidence that AAH may progress from low to high grade to bronchioloalveolar carcinoma (BAC; a non-invasive lesion by definition). Invasion then develops within BAC and peripheral lung adenocarcinoma evolves. The molecular events associated with this progression are not well understood and studies are hampered by a lack of clear criteria to distinguish high grade AAH from BAC. Nonetheless, as with SD/CIS, the patterns of expression of tumour associated genes are consistent with neoplastic progression. We have little idea of the incidence of AAH in the normal or "smoking" populations. It is found more frequently in cancer bearing lungs, especially in those with adenocarcinoma, and is more common in women. No data are available on the risk of progression of AAH. DIPNECH is an exceptionally rare lesion associated with the development of multiple carcinoid tumours. Almost nothing is known of its biology.

Knowledge of these lesions will be crucial in the design and understanding of lung cancer screening programmes, where it is likely that the morphological and, more importantly perhaps, the molecular characteristics of these lesions will provide useful targets for detection and possibly even treatment.

Key Words: lung cancer • preneoplasia • carcinogenesis

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Sorrentino, C., Di Carlo, E. (2009). Expression of IL-32 in Human Lung Cancer Is Related to the Histotype and Metastatic Phenotype. Am. J. Respir. Crit. Care Med. 180: 769-779 [Abstract] [Full Text]  
• Behrens, C., Lin, H. Y., Lee, J. J., Raso, M. G., Hong, W. K., Wistuba, I. I., Lotan, R. (2008). Immunohistochemical Expression of Basic Fibroblast Growth Factor and Fibroblast Growth Factor Receptors 1 and 2 in the Pathogenesis of Lung Cancer. Clin. Cancer Res. 14: 6014-6022 [Abstract] [Full Text]  
• Franks, T. J., Colby, T. V., Travis, W. D., Tuder, R. M., Reynolds, H. Y., Brody, A. R., Cardoso, W. V., Crystal, R. G., Drake, C. J., Engelhardt, J., Frid, M., Herzog, E., Mason, R., Phan, S. H., Randell, S. H., Rose, M. C., Stevens, T., Serge, J., Sunday, M. E., Voynow, J. A., Weinstein, B. M., Whitsett, J., Williams, M. C. (2008). Resident Cellular Components of the Human Lung: Current Knowledge and Goals for Research on Cell Phenotyping and Function. Proc Am Thorac Soc 5: 763-766 [Abstract] [Full Text]  
• Haworth, R., Woodfine, J., McCawley, S., Pilling, A. M., Lewis, D. J., Williams, T. C. (2007). Pulmonary Neuroendocrine Cell Hyperplasia: Identification, Diagnostic Criteria and Incidence in Untreated Ageing Rats of Different Strains. Toxicol Pathol 35: 735-740 [Abstract] [Full Text]  
• Pelosi, G., Del Curto, B., Trubia, M., Nicholson, A. G., Manzotti, M., Veronesi, G., Spaggiari, L., Maisonneuve, P., Pasini, F., Terzi, A., Iannucci, A., Viale, G. (2007). 3q26 Amplification and Polysomy of Chromosome 3 in Squamous Cell Lesions of the Lung: A Fluorescence In situ Hybridization Study. Clin. Cancer Res. 13: 1995-2004 [Abstract] [Full Text]  
• Chiosea, S., Jelezcova, E., Chandran, U., Luo, J., Mantha, G., Sobol, R. W., Dacic, S. (2007). Overexpression of Dicer in Precursor Lesions of Lung Adenocarcinoma. Cancer Res. 67: 2345-2350 [Abstract] [Full Text]  
• Thiberville, L., Moreno-Swirc, S., Vercauteren, T., Peltier, E., Cave, C., Bourg Heckly, G. (2007). In Vivo Imaging of the Bronchial Wall Microstructure Using Fibered Confocal Fluorescence Microscopy. Am. J. Respir. Crit. Care Med. 175: 22-31 [Abstract] [Full Text]  
• Lucattelli, M., Fineschi, S., Geppetti, P., Gerard, N. P., Lungarella, G. (2006). Neurokinin-1 Receptor Blockade and Murine Lung Tumorigenesis. Am. J. Respir. Crit. Care Med. 174: 674-683 [Abstract] [Full Text]  
• Johney, E. C., Pfannschmidt, J., Rieker, R. J., Schnabel, P. A., Mechtersheimer, G., Dienemann, H. (2006). Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia and a typical carcinoid tumor. J. Thorac. Cardiovasc. Surg. 131: 1207-1208 [Full Text]  
• Winer-Muram, H. T. (2006). The solitary pulmonary nodule.. Radiology 239: 34-49 [Abstract] [Full Text]  
• Kim, I.-M., Ackerson, T., Ramakrishna, S., Tretiakova, M., Wang, I-C., Kalin, T. V., Major, M. L., Gusarova, G. A., Yoder, H. M., Costa, R. H., Kalinichenko, V. V. (2006). The Forkhead Box m1 Transcription Factor Stimulates the Proliferation of Tumor Cells during Development of Lung Cancer. Cancer Res. 66: 2153-2161 [Abstract] [Full Text]  
• Ma, Y., Lin, D., Sun, W., Xiao, T., Yuan, J., Han, N., Guo, S., Feng, X., Su, K., Mao, Y., Cheng, S., Gao, Y. (2006). Expression of Targeting Protein for Xklp2 Associated with Both Malignant Transformation of Respiratory Epithelium and Progression of Squamous Cell Lung Cancer. Clin. Cancer Res. 12: 1121-1127 [Abstract] [Full Text]  
• Breuer, R. H., Pasic, A., Smit, E. F., van Vliet, E., Vonk Noordegraaf, A., Risse, E. J., Postmus, P. E., Sutedja, T. G. (2005). The Natural Course of Preneoplastic Lesions in Bronchial Epithelium. Clin. Cancer Res. 11: 537-543 [Abstract] [Full Text]  
• Ruffini, E., Bongiovanni, M., Cavallo, A., Filosso, P.L., Giobbe, R., Mancuso, M., Molinatti, M., Oliaro, A. (2004). The significance of associated pre-invasive lesions in patients resected for primary lung neoplasms. Eur. J. Cardiothorac. Surg. 26: 165-172 [Abstract] [Full Text]  
• Nikitin, A. Yu., Alcaraz, A., Anver, M. R., Bronson, R. T., Cardiff, R. D., Dixon, D., Fraire, A. E., Gabrielson, E. W., Gunning, W. T., Haines, D. C., Kaufman, M. H., Linnoila, R. I., Maronpot, R. R., Rabson, A. S., Reddick, R. L., Rehm, S., Rozengurt, N., Schuller, H. M., Shmidt, E. N., Travis, W. D., Ward, J. M., Jacks, T. (2004). Classification of Proliferative Pulmonary Lesions of the Mouse: Recommendations of the Mouse Models of Human Cancers Consortium. Cancer Res. 64: 2307-2316 [Abstract] [Full Text]  
• Libby, D. M., Smith, J. P., Altorki, N. K., Pasmantier, M. W., Yankelevitz, D., Henschke, C. I. (2004). Managing the Small Pulmonary Nodule Discovered by CT. Chest 125: 1522-1529 [Abstract] [Full Text]  
• Stenhouse, G, Fyfe, N, King, G, Chapman, A, Kerr, K M (2004). Thyroid transcription factor 1 in pulmonary adenocarcinoma. J. Clin. Pathol. 57: 383-387 [Abstract] [Full Text]  
• Fedorov, L. M., Papadopoulos, T., Tyrsin, O. Y., Twardzik, T., Gotz, R., Rapp, U. R. (2003). Loss of p53 in craf-induced Transgenic Lung Adenoma Leads to Tumor Acceleration and Phenotypic Switch. Cancer Res. 63: 2268-2277 [Abstract] [Full Text]  
• Sutedja, G. (2003). New techniques for early detection of lung cancer. Eur Respir J 21: 57S-66s [Abstract] [Full Text]  
• Spiro, S. G., Porter, J. C. (2002). Lung Cancer--Where Are We Today?: Current Advances in Staging and Nonsurgical Treatment. Am. J. Respir. Crit. Care Med. 166: 1166-1196 [Abstract] [Full Text]  
• Fedorov, L. M., Tyrsin, O. Yu., Papadopoulos, T., Camarero, G., Gotz, R., Rapp, U. R. (2002). Bcl-2 Determines Susceptibility to Induction of Lung Cancer by Oncogenic CRaf. Cancer Res. 62: 6297-6303 [Abstract] [Full Text]  
• Seki, N., Takasu, T., Mandai, K., Nakata, M., Saeki, H., Heike, Y., Takata, I., Segawa, Y., Hanafusa, T., Eguchi, K. (2002). Expression of Eukaryotic Initiation Factor 4E in Atypical Adenomatous Hyperplasia and Adenocarcinoma of the Human Peripheral Lung. Clin. Cancer Res. 8: 3046-3053 [Abstract] [Full Text]  
• Jackson, E. L., Willis, N., Mercer, K., Bronson, R. T., Crowley, D., Montoya, R., Jacks, T., Tuveson, D. A. (2001). Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev. 15: 3243-3248 [Abstract] [Full Text]